Table 1.
Baseline characteristics of 4 subjects
| Subject No. | Sex/Age (yr) | Disease | Gastric pH | Site | Intesinal metaplasia (n) | Neutrophil infiltration (n) | Monocyte infiltration (n) | Atrophy (n) | CLO | H&E | Culture | HP IgG | Eradication history | PG I/II ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M/44 | EGC | 7.4 | Body | 0 | 2 | 3 | 0 | + | Moderate | Positive | N/A | No | 2.5 |
| Antrum | 1 | |||||||||||||
| 2 | F/59 | Gastritis | 1.25 | Body | 0 | 2 | 2 | Ina | + | Moderate | Positive | 1.975 | No | 1.9 |
| Antrum | 1 | |||||||||||||
| 3 | M/54 | AGC | 1 | Body | 0 | 2 | 2 | Ina | + | Mild | N/A | N/A | No | 3.0 |
| Antrum | 2 | |||||||||||||
| 4 | F/38 | Control | 1.51 | Body | 0 | 0 | 1 | Ina | - | - | N/A | N/A | No | 5.7 |
| Antrum | 0 |
CLO, Campylobacter-like organism; HP IgG, Helicobacter pylori immunoglobulin G; PG, pepsinogen; M, male; F, female; EGC, early gastric cancer; AGC; advancedgastric cancer; Ina, inadequate to assess atrophy; N/A, not assessed.